Connect with us

Health

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

Published

on

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

Newer and more expensive medications are more likely to be made in the United States or Europe. Ireland, in particular, has become a hub because it is a tax haven.

Many of the industry’s biggest blockbusters are manufactured at least partly in Ireland. Among them are: Keytruda, Merck’s cancer drug; Zepbound, Eli Lilly’s weight-loss drug; and Stelara, Johnson & Johnson’s anti-inflammatory drug used for conditions like arthritis.

Mr. Trump has taken notice. “This beautiful island of five million people has got the entire U.S. pharmaceutical industry in its grasp,” he said in March at a meeting with Prime Minister Micheal Martin of Ireland.


U.S. production of pharmaceuticals peaked, by one measure, in 2006.

That was around the time a wave of top-selling American-made drugs lost patent protection, creating opportunities for generic manufacturers in India and China to ramp up production of generics. Around the same time, U.S. government incentives to manufacture in Puerto Rico were phased out, while new carrots, like tax advantages in Ireland, encouraged manufacturers to move production overseas.

Advertisement

In 2021, most of America’s top-consumed generic drugs, as well as key antibiotics and antivirals, had no American facility producing their active ingredients, according to Clarivate.

Mr. Trump said on Wednesday that “the United States can no longer produce enough antibiotics to treat our sick.”

For example, nearly all the world’s sites producing the active ingredient of amoxicillin, a common antibiotic, are in China, India or Europe, according to Clarivate.

A Tennessee plant, now owned by a company called USAntibiotics, used to supply nearly all of the amoxicillin consumed in the United States. It now imports the active ingredient from Europe and uses it to formulate pills. The plant now supplies about 5 percent of America’s amoxicillin.

Medications are usually protected from tariffs under a World Trade Organization agreement aimed at protecting patients’ access to vital drugs. The tariffs that Mr. Trump imposed on certain imports in his first term did not hit pharmaceuticals.

Advertisement

Starting in February, drugmakers importing active ingredients made in China into the United States have had to pay a tariff that Mr. Trump imposed on Chinese goods. That tariff rose to 20 percent in March. (Wednesday’s levies add a new 34 percent tariff on most Chinese imports, though that does not apply to medicines.)


For the manufacturers of inexpensive generic drugs with razor-thin profit margins, the added costs of tariffs could be “a tipping point” that prompts them to exit the market, said Erin Fox, an expert at the University of Utah who tracks drug shortages.

Dr. Fox said she was most worried about drugs for which shortages are already common, such as generic medications given as an injection. These injections are harder to make than pills and are much less profitable than newer medications, discouraging manufacturers from jumping in. An example is lidocaine, used to numb pain during medical procedures. Most production of lidocaine’s active ingredient is in India, according to Clarivate.

Health

Cancer risk linked to common blood-related condition, research reveals

Published

on

Cancer risk linked to common blood-related condition, research reveals

NEWYou can now listen to Fox News articles!

Anemia, a common blood disorder, may be a major risk factor for developing cancer.

Advertisement

That’s according to new research from Sweden, which sought to discover whether newly developed anemia is an early warning sign of cancer or death from any cause.

The study, published in BMJ Journals, looked at registry data from more than 380,000 Swedish adults – half were people with new-onset anemia and the other half were the same age and gender, but did not have anemia.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

All participants were over 18 years old and cancer-free at the start of the study.

The results showed that people with incident anemia – new cases occurring over a specific period – had a significantly higher chance of being diagnosed with cancer, especially in the first three months, according to a press release. This included 6.2% of men and 2.8% of women.

Advertisement

Anemia, a common blood disorder, may be a major risk factor for developing cancer. (iStock)

Individuals with anemia also had a much higher chance of death during the 18-month follow-up.

Specific types of anemia were individually linked to disease progression and mortality, the researchers discovered.

CLICK HERE FOR MORE HEALTH STORIES

Microcytic anemia – where the red blood cells are smaller than normal – was more frequently linked to cancer, especially types of disease that impact the digestive system and the blood.

Advertisement

Macrocytic anemia, a type of anemia where the red blood cells are larger than normal, was more strongly linked to overall mortality than cancer.

The researchers concluded in the study that new-onset anemia is a “strong and sustained risk marker” for both incident cancer and all-cause mortality. (iStock)

The researchers concluded in the study that new-onset anemia is a “strong and sustained risk marker” for both incident cancer and all-cause mortality.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Lead study author Elinor Nemlander, researcher at the Department of Neurobiology, Care Sciences and Society at the Karolinska Institutet, commented on the findings in a press release from the Swedish medical university.

Advertisement

“We found that both the risk of cancer and the risk of death are highest during the first months after anemia is detected, but that the increased risk persists later during follow-up as well,” she said. “Our findings suggest that anemia may be a sign of underlying disease rather than a condition in its own right.”

Specific types of anemia were individually linked to disease progression and mortality, the researchers discovered. (iStock)

Speaking with Fox News Digital, Nemlander noted that measures like red blood cell size are already “routinely available” in primary care, and that the study highlights how this existing data can be used to identify early risk.

“At the same time, the elevated risks persist over time, underscoring the need for structured follow-up and clear plans for continued evaluation, even when cancer is not initially identified,” she said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

As the study was observational, it shows an association, but does not prove that anemia causes cancer or death.

The research also did not measure for all causes of anemia, including alcohol use, malnutrition, chronic liver disease, inflammatory conditions and gynecological blood loss.

“Some of the results may also be influenced by who gets tested, underlying illnesses and differences in how anemia is evaluated in different healthcare settings,” Nemlander added.

Continue Reading

Health

More patients demand ‘unvaccinated’ blood, doctors warn of growing health risks

Published

on

More patients demand ‘unvaccinated’ blood, doctors warn of growing health risks

NEWYou can now listen to Fox News articles!

An increasing number of patients are requesting “unvaccinated” blood for transfusions, which can delay care and pose risks to patients’ health, experts warn.

There is no evidence that unvaccinated blood presents any safety benefit, according to a new study published in the journal Transfusion.

There is currently no process for checking whether donated blood comes from vaccinated or unvaccinated donors, experts say.

CANCER SURVIVAL APPEARS TO DOUBLE WITH COMMON VACCINE, RESEARCHERS SAY

Advertisement

Vanderbilt University in Tennessee, which conducted the research, received 15 requests for unvaccinated blood between Jan. 1, 2024, and Dec. 31, 2025. The median age of patients was 17 years old and more than half were children, the university reported.

An increasing number of patients are requesting “unvaccinated” blood for transfusions, which can delay care and pose risks to patients’ health, experts warn. (iStock)

Thirteen of the patients received blood donated specifically for them by family members, which is known as “direct donation.” This can be risky, because most direct donors are giving blood for the first time, and their donations are more likely to contain “potentially harmful pathogens,” the authors noted. 

“Despite being framed as ‘safer,’ directed donations may paradoxically increase risk.”

COVID VACCINE UNDER NEW SCRUTINY AFTER STUDIES REVEAL POSSIBLE HEALTH RISKS

Advertisement

Among the studied patient group, two became much sicker after refusing a standard blood transfusion. 

One patient developed anemia, a condition where the body lacks enough healthy red blood cells to carry adequate oxygen. The other developed hemodynamic shock, a serious condition in which there is insufficient blood flow and oxygen to the body’s tissues, potentially leading to organ failure.

“Despite being framed as ‘safer,’ directed donations may paradoxically increase risk.”

Requests for unvaccinated blood spiked after the approval of COVID-19 vaccines, posing a “recurring challenge for transfusion services and clinicians,” the researchers stated.

“These requests were associated with care delays, escalation and inefficiencies,” they indicated.

Advertisement

FAMILY PLEADS FOR HELP AS TEEN FACES LIFE-THREATENING BONE MARROW FAILURE

The researchers recommend that health systems create standardized policies to handle these types of requests.

“Regulatory and professional organizations have opposed these non-evidence-based policies, emphasizing that blood centers do not record or convey donor COVID-19 vaccination status and that evidence demonstrates transfusion from vaccinated donors poses no unique risk.”

Requests for unvaccinated blood spiked after the approval of COVID-19 vaccines, posing a “recurring challenge for transfusion services and clinicians,” the researchers stated. (Reuters/Dado Ruvic/Illustration/File Photo)

The Vanderbilt study had some limitations, the researchers noted. It looked at a small number of cases and only included situations where special blood donations made it to the blood bank, so it doesn’t show how often people made this request overall. 

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

It also didn’t include cases where concerns were resolved through conversations with doctors or ethics teams, the team noted.

As this was an observational study and not a controlled experiment, it only showed an association and could not prove that refusing standard blood directly caused any specific patient outcomes.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Several states have introduced proposals aimed at allowing patients to receive blood specifically from donors who have not received COVID-19 vaccines.

Advertisement

In Oklahoma, one such proposal called for the creation of a state-run blood bank dedicated to collecting and distributing blood from unvaccinated donors. Despite these efforts, none of the measures have been enacted into law.

The notion that receiving blood from someone who had the vaccine would be harmful is not based on any scientific studies, doctors say. (iStock)

Dr. Marc Siegel, Fox News senior medical analyst, was not involved in the research, but said these types of requests are “part of an ongoing fear culture.”

“It is also very difficult to test for, because the antibodies may be positive from COVID itself as well as the vaccine, and it can be difficult to tell the difference,” he told Fox News Digital.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

The notion that receiving blood from someone who had the vaccine would be harmful is not based on any scientific studies, the doctor reiterated.

“If people want to group up to get blood from other unvaccinated people, I respect that choice, though it will be expensive and will limit options,” Siegel added.

“Requests for unvaccinated blood are something we’ve seen wax and wane since the introduction of the COVID vaccine,” an expert said. (iStock)

Diane Calmus, vice president of government affairs for America’s Blood Centers in Washington, D.C., said that requests for direct donations are “exceedingly rare” – representing about 0.06% of the U.S. blood supply.

“Requests for unvaccinated blood are something we’ve seen wax and wane since the introduction of the COVID vaccine,” Calmus, who also was not involved in the Vanderbilt study, told Fox News Digital. “The challenge is that there’s no way to tell whether someone’s blood has been vaccinated – there’s no test that exists.”

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Any situation where someone requires a blood transfusion is most likely a “very scary time,” she noted.

“Family members want to be cautious, and this is why it’s so important that people talk to a transfusion medicine-trained doctor,” the expert advised. “These are physicians who have a specialty in blood transfusions … and who can answer those questions that any individual will have.”

“Blood has to be prescribed. You can’t just show up at the blood center and say, ‘I would like my sister to donate for me,’” an expert said. (iStock)

Calmus pointed out that it takes some time to facilitate a direct donation, and that there is a specific process in place. 

Advertisement

“Blood has to be prescribed. You can’t just show up at the blood center and say, ‘I would like my sister to donate for me,’” she said. “There needs to be a prescription. It needs to go through the hospital … they need to make sure it is the right blood for the right patient.”

“We need people – vaccinated or not vaccinated – to show up and donate blood, because it is the blood on the shelves that saves lives.”

Calmus emphasized that the U.S. blood supply is “meticulously tracked,” and that there have been no indications of a lack of safety. She also stressed the ongoing need for blood donors.

“We need people – vaccinated or not vaccinated – to show up and donate blood, because it is the blood on the shelves that saves lives.”

Fox News Digital reached out to the Vanderbilt researchers for comment.

Advertisement

Continue Reading

Health

She Lost 101 Lbs by Flipping the Food Pyramid—Here’s How You Can Too

Published

on

She Lost 101 Lbs by Flipping the Food Pyramid—Here’s How You Can Too


Advertisement





New Food Pyramid for Weight Loss Helped Her Drop 101 Pounds




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending